Clinical Trial Update: Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating pazopanib hydrochloride with or without ascorbic acid in metastatic or unresectable clear cell renal cell carcinoma was terminated wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• Ascorbic acid (Vitamin C)
• Pazopanib hydrochloride (pazopanib)

Snippet

Sponsor: Academic and Community Cancer Research United | Conditions: Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2022-03-16